ARWEN PODESTA: Open Payments
NPI 1194914598 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168,866 in 183 payments from 11 companies in 2025. Trend: 2023 $57,957 · 2024 $101,350 · 2025 $168,866
Honoraria: $75,027Consulting: $42,858Speaker / faculty: $23,906Travel & lodging: $23,232Food & beverage: $3,804Education: $39
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 46 | $43,396 |
| Braeburn Inc. | 62 | $43,234 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 10 | $23,434 |
| Indivior Inc. | 23 | $17,307 |
| Alkermes, Inc. | 9 | $14,462 |
| ABBVIE INC. | 22 | $13,711 |
| Eli Lilly and Company | 6 | $9,888 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $3,350 |
| Lundbeck LLC | 1 | $39 |
| PFIZER INC. | 2 | $30 |
Products named: Auvelity, BRIXADI, REJOYN, SUBLOCADE, VIVITROL, VRAYLAR, REXULTI, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
